On March 24, 2021 on the website of the Russian journal of Infection and Immunity an article was published by the Novosibirsk Center "Vector" on the results of a study of the work of the vaccine "EpiVacCorona". Clinical studies have shown that, 21 days after administration of this drug, antibodies are produced in 100% of volunteers. Moreover, the effectiveness of the drug against all known strains of covid was studied. The paper will be published in the second issue of the 11th volume of the journal.